InsidersTradesSigma
Follow the 株式会社ペルセウスプロテオミクス stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社ペルセウスプロテオミクス has logged 40 public disclosures. Market capitalisation: €2.5bn. The latest transaction was disclosed on 3 July 2026 (Holding update). Among the most active insiders: SBI SECURITIES Co.,Ltd.. All data is free.
40
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,624 of 28,549 companies
28.6
score / 100
Value8
Quality49
FCF yld-27%
Earn yld-29%
EV/EBITDA·
ROE-60%
Gross mgn86%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations40 total
ShareXTKSEDINET:S100YO2V
ShareXTKSEDINET:S100XZOE
ShareXTKSEDINET:S100XRMC
3.1% of flowShareXTKSEDINET:S100XR0J
4.2% of flowShareXTKSEDINET:S100XQH7
65.5% of flowShareXTKSEDINET:S100XPY4
26.1% of flowShareXTKSEDINET:S100XMRD
8.5% of flowShareXTKSEDINET:S100XEUI
ShareXTKSEDINET:S100WAOU
ShareXTKSEDINET:S100VYJL
ShareXTKSEDINET:S100VVLE
ShareXTKSEDINET:S100VPE2
ShareXTKSEDINET:S100VN00
ShareXTKSEDINET:S100VCDQ
ShareXTKSEDINET:S100V9QT
ShareXTKSEDINET:S100UTBL
ShareXTKSEDINET:S100UJRP
ShareXTKSEDINET:S100TZ40
ShareXTKSEDINET:S100TKFY
ShareXTKSEDINET:S100TCQY
ShareXTKSEDINET:S100TAEK
16.2% of flowShareXTKSEDINET:S100T8RW
16.3% of flowShareXTKSEDINET:S100T8QT
16.2% of flowShareXTKSEDINET:S100T7H7
16.4% of flowShareXTKSEDINET:S100T3B0
25 of 40 declarations
Acerca de 株式会社ペルセウスプロテオミクス
Perseus Proteomics Co., Ltd. es una empresa especializada en proteómica, que ofrece soluciones innovadoras para la investigación en salud y farmacéutica. Cotiza en el mercado XTKS.